Vitamin K
(MBWXNTAXLNYFJB-LKUDQCMESA-N)
Structure
- SMILES
- CC(CCCC(CCCC(C)C)C)CCC/C(=C/CC1=C(C)C(=O)c2c(C1=O)cccc2)/C
- Molecular Formula:
- C31H46O2
- Molecular Weight:
- 450.696
- Log P:
- 9.1576
- Hydrogen Bond Acceptor:
- 2
- Hydrogen Bond Donor:
- 0
- TPSA:
- 34.14
- CAS Number(s):
- 10485-69-5; 12001-79-5; 27696-10-2; 81818-54-4
Synonym(s)
1.
Vitamin K
External Link(s)
| MeSH | D014812 |
| PubChem Compound | 5280483 |
| ChEBI | 94399 |
| CHEMBL | CHEMBL520156 |
| KEGG | cpd:C02059 dr:D00148 |
| Therapeutic Target Database | D07QPA |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 4 | US FAERS | |
| 2 | Hypotension | FAERS: 4 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 3 | Vomiting | FAERS: 3 | US FAERS | |
| 4 | Cardiac Arrest | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Medication Error | FAERS: 2 | US FAERS | |
| 6 | jaundice | FAERS: 2 | US FAERS | |
| 7 | Adverse event | FAERS: 1 | US FAERS | |
| 8 | Agitation | FAERS: 1 | US FAERS | |
| 9 | Amyloidosis | FAERS: 1 | US FAERS | |
| 10 | Angioedema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Atrial thrombosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Bradycardia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Burning sensation | FAERS: 1 | US FAERS | |
| 14 | Cerebrovascular accident | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Chest Pain | FAERS: 1 | US FAERS | |
| 16 | Chest discomfort | FAERS: 1 | US FAERS | |
| 17 | Chills | FAERS: 1 | US FAERS | |
| 18 | Cyanosis | FAERS: 1 Canada Vigilance: 2 | 9382401 | CTD Canada Vigilance US FAERS |
| 19 | Deep Vein Thrombosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 21 | Drug label confusion | FAERS: 1 | US FAERS | |
| 22 | Factor X Deficiency | FAERS: 1 | US FAERS | |
| 23 | Flushing | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 24 | Inability to afford medication | FAERS: 1 | US FAERS | |
| 25 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 26 | Inflammation | FAERS: 1 | US FAERS | |
| 27 | Inflammatory marker increased | FAERS: 1 | US FAERS | |
| 28 | Infusion site warmth | FAERS: 1 | US FAERS | |
| 29 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 30 | Intercepted product dispensing error | FAERS: 1 | US FAERS | |
| 31 | Malabsorption | FAERS: 1 | US FAERS | |
| 32 | Malaise | FAERS: 1 | US FAERS | |
| 33 | Neutropenia | FAERS: 1 | US FAERS | |
| 34 | No adverse event | FAERS: 1 | US FAERS | |
| 35 | Pallor | FAERS: 1 | US FAERS | |
| 36 | Peripheral swelling | FAERS: 1 | US FAERS | |
| 37 | Poisoning | FAERS: 1 | US FAERS | |
| 38 | Poor feeding infant | FAERS: 1 | US FAERS | |
| 39 | Product dispensing error | FAERS: 1 | US FAERS | |
| 40 | Product formulation issue | FAERS: 1 | US FAERS | |
| 41 | Product packaging confusion | FAERS: 1 | US FAERS | |
| 42 | Product selection error | FAERS: 1 | US FAERS | |
| 43 | Respiratory Failure | FAERS: 1 | US FAERS | |
| 44 | Respiratory arrest | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Splenomegaly | FAERS: 1 | US FAERS | |
| 46 | Tachycardia | FAERS: 1 | US FAERS | |
| 47 | Urticaria | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 48 | Visual disturbance | FAERS: 1 | US FAERS | |
| 49 | Wheezing | FAERS: 1 | US FAERS | |
| 50 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 51 | Arterial calcification of infancy | 25758222 | CTD | |
| 52 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 53 | Blood Coagulation Disorders | 4049235 9681093 | CTD | |
| 54 | Bronchospasm | Canada Vigilance: 1 | Canada Vigilance | |
| 55 | Cerebral Hemorrhage | 16306465 | CTD | |
| 56 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 57 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 58 | Ecchymosis | Canada Vigilance: 1 | Canada Vigilance | |
| 59 | Erythema | Canada Vigilance: 2 | Canada Vigilance | |
| 60 | Femoral Neuropathy | 4338821 | CTD | |
| 61 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 62 | Hemorrhage | 18049162 23117658 | CTD | |
| 63 | Hepatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 64 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 65 | Hyperventilation | Canada Vigilance: 1 | Canada Vigilance | |
| 66 | Injection Site Reaction | Canada Vigilance: 2 | Canada Vigilance | |
| 67 | Liver Failure | 11316203 | CTD | |
| 68 | Muscle Rigidity | Canada Vigilance: 1 | Canada Vigilance | |
| 69 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 70 | Necrosis | 1284839 | CTD | |
| 71 | Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 72 | Pruritus | Canada Vigilance: 2 | Canada Vigilance | |
| 73 | Pseudoxanthoma Elasticum | 25758222 | CTD | |
| 74 | Shock | Canada Vigilance: 1 | Canada Vigilance | |
| 75 | Skin reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 76 | Stridor | Canada Vigilance: 1 | Canada Vigilance | |
| 77 | Swelling | Canada Vigilance: 2 | Canada Vigilance | |
| 78 | Vasospasm | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.